Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/2010
01/12/2010CA2443365C Methods for the recombinant production of antifusogenic peptides
01/12/2010CA2438143C Modified proteins, designer toxins, and methods of making thereof
01/12/2010CA2340974C Method for purifying proteins and/or biomolecule or protein complexes
01/12/2010CA2293731C Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use
01/12/2010CA2290217C Peptides for the detection of hiv-1 group o
01/12/2010CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
01/12/2010CA2201781C Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component
01/07/2010WO2010002862A2 Fibroblast growth factor receptor 3 (fgfr3) binding proteins
01/07/2010WO2010002468A1 A functional complementation assay for defined gpcr oligomers
01/07/2010WO2010002042A1 Enzyme substrate for labeling of protein
01/07/2010WO2010001960A1 Method for production of recombinant protein by using genetically engineered brevibacillus bacterium
01/07/2010WO2010001908A1 Anti-cd27 antibody
01/07/2010WO2010001659A1 Method for production of preparation containing single useful substance having polypeptide
01/07/2010WO2010000025A1 Anti-pamp therapeutic antibodies
01/07/2010WO2009140348A3 Anti-il-6/il-6r antibodies and methods of use thereof
01/07/2010WO2009137677A3 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus
01/07/2010WO2009134368A3 Methods of producing bacterial alginates
01/07/2010WO2009123950A3 Chimera comprising bacterial cytotoxin and methods of using the same
01/07/2010WO2009123894A3 Her2/neu-specific antibodies and methods of using same
01/07/2010WO2009100255A3 Modified leptin polypeptides and their uses
01/07/2010WO2009076292A3 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome
01/07/2010WO2009064944A3 Antibodies to lrp6
01/07/2010WO2008097870A3 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr)
01/07/2010US20100005543 Toxin genes and methods for their use
01/07/2010US20100005536 Promoter for Introducing a Gene into a Lymphocyte or Blood Cell and Application Thereof
01/07/2010US20100004433 Novel collagen-like protein clac, precursor thereof and genes encoding the same
01/07/2010US20100004429 Agonist antibody to human thrombopoietin receptor
01/07/2010US20100004277 Compounds and methods for modulating protein trafficking
01/07/2010US20100004183 Mineral collagen chelates and methods of making and using same
01/07/2010US20100004175 Novel bmp-12-related proteins and methods of their manufacture
01/07/2010US20100004167 Csf3r polypeptides and uses thereof
01/07/2010US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof
01/07/2010US20100003722 Production of IL-29 from E. coli requires that the aggregated proteins be solubilized from the insoluble inclusion bodies and renatured or refolded; Without renaturation, the specific activity of the recombinant protein will be significantly reduced; higher yields
01/07/2010US20100003721 Human interferon-beta mutein
01/07/2010US20100003720 Enzyme derived from thermophilic organisms that functions as a chromosomal replicase, and preparation and uses thereof
01/07/2010US20100003719 Trimerising Module
01/07/2010US20100003718 Method and apparatus for the production of soluble mhc antigens and uses thereof
01/07/2010US20100003682 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
01/07/2010US20100003673 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders
01/07/2010US20100003365 Cloning, expression and use of acid phospholipases
01/07/2010US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening
01/07/2010US20100003261 agonist anti-trk-c monoclonal antibodies
01/07/2010US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
01/07/2010US20100003258 Fibroblast growth factor receptor 3 (fgfr3) binding proteins
01/07/2010DE102008032828A1 Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel Tryptophan-containing peptides from alpha-lactalbumin with antihypertensive and vasoprotective effect for biofunctional food
01/07/2010CA2729567A1 Anti-cd27 antibody
01/06/2010EP2141243A2 Protein scaffolds for antibody mimics and other binding proteins
01/06/2010EP2141175A1 Process for synthesizing cyclic peptide compound
01/06/2010EP2141174A1 Column packing and column for refolding protein
01/06/2010EP2141120A1 High throughput discovery of materials through vapor phase synthesis
01/06/2010EP2140268A1 Method for controlling glucose uptake and insulin sensitivity
01/06/2010EP2140147A2 Clip-on, clip off mounting device as for a portable light
01/06/2010EP2140015A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
01/06/2010EP2140008A2 Yeast expression systems
01/06/2010EP2139996A1 Peptidases from basidiomycetes
01/06/2010EP2139986A1 Use of low temperature and/or low ph in cell culture
01/06/2010EP1824986B1 Biomaterial which can successively carry out a solution/gel transition then a gel/solution transition
01/06/2010EP1476562B1 Over-expression of extremozyme genes in pseudomonads and closely related bacteria
01/06/2010EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor
01/06/2010EP1432722B1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses
01/06/2010EP1409018B1 Stable lyophilized pharmaceutical formulation the igg antibody daclizumab
01/06/2010EP1032417B1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens
01/06/2010CN101619339A Production method of bacterial exotoxin
01/06/2010CN101619338A Method for producing genistein protein powder by using natto bacilli to ferment soybean meal
01/06/2010CN100577809C Enzymes having alpha amylase activity and method of use thereof
01/06/2010CN100577804C Novel mutant allergens
01/06/2010CN100577682C Method for designing and preparing small peptide
01/05/2010US7642345 Polynucleotides encoding human cytokine receptor
01/05/2010US7642341 Antibody fragments are selected from Fab fragments, Fv fragments, single domain antigen binding fragments, scFv and aggregates thereof; for treatment of solid tumor carcinomas
01/05/2010US7642236 Recombinant lubricin molecules and uses thereof
01/05/2010US7642228 Method for making heteromultimeric polypeptides
01/05/2010US7642083 Generation of hydroquinone and derivatives; obtain quinic acid, oxidize to 3,4,5-trihydroxycyclohexanone, convert 3,4,5-trihydroxycyclohexanone to hydroquinone
01/05/2010US7642081 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
01/05/2010US7642078 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally; glycosylation of recombinant proteins when produced in adenovirus E1A-expressing cells
01/05/2010US7642072 Optimized interferon-beta gene
01/05/2010US7642071 Expressing Gram-negative glycosaminoglycan synthase gene in a Gram-positive bacterial host background to produce GAGs by fermentation in vivo; providing a purified nucleic acid segment encoding an enzymatically active chondroitin synthase
01/05/2010US7642069 Process for the intracellular over-production of streptokinase using genetically engineered strain of E. coli
01/05/2010US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate)
01/05/2010US7641910 Amino acid sequence or immunogenic fragment of at least 15 contiguous amino acid sequence when administered to a subject induce antibody or T-cell mediated immune response that recognizes polypeptide
01/05/2010US7641904 IL-32 monoclonal antibodies and uses thereof
01/05/2010US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells
01/05/2010US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16
01/05/2010CA2592555C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus
01/05/2010CA2456183C Il-6/ds-sil-6r fusion protein
01/05/2010CA2381995C Method for the production of proteinaceous substances
01/05/2010CA2290717C Nucleic acid binding proteins
01/05/2010CA2281877C Psca: prostate stem cell antigen
01/05/2010CA2234119C Improved barstar gene
01/05/2010CA2184636C Immunoenzymatic conjugate, preparation method therefor and uses thereof
01/05/2010CA2182810C Bacteriocin from micrococcus varians
01/05/2010CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
12/2009
12/31/2009US20090328259 Polypeptides having endoglucanase activity and polynucleotides encoding same
12/31/2009US20090328254 Novel vip3 toxins and methods of use
12/31/2009US20090328251 Galactosyltransferase
12/31/2009US20090328249 Transplastomic Plants Expressing Lumen-Targeted Protein
12/31/2009US20090326204 Interferon-like protein zcyto21
12/31/2009US20090325880 Tnf receptor-like molecules and uses thereof
12/31/2009US20090325875 Muteins of human tear lipocalin
12/31/2009US20090325873 Human glp-1 mimetibodies, compositions, methods and uses
12/31/2009US20090325866 Non-activated wnt inhibition polypeptides and method for preparing the same